Andrea Ellis - Net Worth and Insider Trading

Andrea Ellis Net Worth

The estimated net worth of Andrea Ellis is at least $430,680 dollars as of 2025-04-29. Andrea Ellis is the Director of BridgeBio Pharma Inc and owns about 12,000 shares of BridgeBio Pharma Inc (BBIO) stock worth over $430,680. Details can be seen in Andrea Ellis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrea Ellis has not made any transactions after 2025-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Andrea Ellis

To

Andrea Ellis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrea Ellis owns 1 companies in total, including BridgeBio Pharma Inc (BBIO) .

Click here to see the complete history of Andrea Ellis’s form 4 insider trades.

Insider Ownership Summary of Andrea Ellis

Ticker Company Transaction Date Type of Owner
BBIO BridgeBio Pharma Inc 2025-04-14 director

Andrea Ellis Latest Holdings Summary

Andrea Ellis currently owns a total of 1 stock. Andrea Ellis owns 12,000 shares of BridgeBio Pharma Inc (BBIO) as of April 14, 2025, with a value of $430,680.

Latest Holdings of Andrea Ellis

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BBIO BridgeBio Pharma Inc 2025-04-14 12,000 35.89 430,680

Holding Weightings of Andrea Ellis


Andrea Ellis Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrea Ellis has made a total of 2 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 10,000 shares on April 14, 2025, which brought Andrea Ellis around $350,000.

Insider Trading History of Andrea Ellis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrea Ellis Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrea Ellis Ownership Network

Ownership Network List of Andrea Ellis

No Data

Ownership Network Relation of Andrea Ellis

Insider Network Chart

Andrea Ellis Owned Company Details

What does BridgeBio Pharma Inc do?

Who are the key executives at BridgeBio Pharma Inc?

Andrea Ellis is the director of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include director & See Remarks Neil Kumar , 10 percent owner Kkr Genetic Disorder L.p. , and See Remarks Brian C Stephenson .

BridgeBio Pharma Inc (BBIO) Insider Trades Summary

Over the past 18 months, Andrea Ellis made 2 insider transaction in BridgeBio Pharma Inc (BBIO) with a net sale of 40,000. Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 962,873 shares made by Neil Kumar , a net sale of 111,644 shares made by Brian C Stephenson , and a net sale of 21,620 shares made by Hannah Valantine .

In summary, during the past 3 months, insiders sold 9,387,682 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 9,387,682 shares. During the past 18 months, 16,111,253 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,111,253 shares.

BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BridgeBio Pharma Inc Insider Transactions

No Available Data

Andrea Ellis Mailing Address

Above is the net worth, insider trading, and ownership report for Andrea Ellis. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrea Ellis's mailing address is: Palo Alto Ca 94301.